	BCDH, branched chain 2-oxoacid dehydrogenase
PPi, pyrophosphate
AMPK, AMP activated protein kinase
IP, ischaemic preconditioning
5HD, 5-hydroxydecanoate
ANT, Adenine nucleotide translocase
MCT1, monocarboxylate transporter 1
MPTP, mitochondrial permeability transition pore
PI-3-kinase, phosphatidyl inositol 3 phosphate kinase
mitoK
PDH, pyruvate dehydrogenase
K
, ATP-dependent potassium channels
Cx43, connexin43
PKC, protein kinase C
ROS, reactive oxygen species
CyP, cyclophilin
PTEN, Phosphatase and TENsin homolog
CrK, creatine kinase
PKG, cyclic GMP-dependent protein kinase
PDK1, phosphoinositide-dependent kinase 1
PPIase, peptidyl-prolyl cis-trans isomerase
APD, Action potential duration
CsA, cyclosporin A
GSK3, glycogen synthase kinase 3
, mitochondrial ATP-dependent potassium channels
SfA, Sanglifehrin A
SUR, sulphohylurea receptor
VDAC, voltage activated anion channel
	mitochondrial protein
ROS production
mitochondrial K channels
opening
proteins
mitochondria
MPTP
activity
sensitive
ROS
increase
pharmacological agents
data
protective
production
reperfusion
ROS levels
effects
ANT
ischaemia
complex
voltage dependent anion channel
membrane
cardiac myocytes
respiratory chain inhibitors
protein kinase C
phosphorylation
deoxyglucose entrapment technique
matrix proteins
IP hearts
experiments
measurements
ROS formation
hearts
light
adenine nucleotides
PKG activators
mechanism
ability
unable
survival kinase cascades
role
kinases
studies
significant depolarisation
oxidative stress
diazoxide
ATP
evidence
pathways
mediated
change
calcium overload
channel Kir 6
intracellular proteins such
respiratory chain
respiratory substrate
response
channel openers
IP protocol
volume
recovery
apoptosis
calcium
result
decrease
formally
CyP-D
critical point
Damage
laboratory
turn
pore
deficient mice
SfA
direct
pharmacological
phosphor-proteins
techniques
consistent
similar
note

